Media Inquiries
Sort by Year
August 26, 2021
Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label
August 5, 2021
Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance
May 26, 2021
February 19, 2021
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
February 8, 2021